What's behind Morpho's latest price surge?

What's behind Morpho's latest price surge?
Morpho surges 12.1% today to $2.502

Morpho (MORPHO) surged 12.1% today on strong technical momentum, as a concentrated wave of buying propelled the token sharply higher. The move is supported by a firm trend above all major moving averages and bullish momentum signals across both short- and long-term indicators.

MORPHO price prediction
24H 3.55%
$2.4812
48H -3.19%
$2.3197
7D -7.26%
$2.2222
1M 17.39%
$2.8127
3M 35.35%
$3.2432
6M 203.47%
$7.2715
12M 918.32%
$24.3999
Current price: $2.3961 -0.0749 3.03%
Real-time Data 17:32
Daily range 2.443 Arrow from to Icon 2.522
Weekly range 2.2800 Arrow from to Icon 2.8180
Loading...

Highlights

  • MORPHO/USD trades above key moving averages, confirming bullish momentum across short-, medium-, and long-term timeframes.
  • Technical indicators show strong buying pressure with overbought conditions, a neutral directional trend, and positive intraday momentum.
  • Near-term resistance is at $2.525 and support is at $2.447, with a projected five-day trading range of $2.2355 to $2.946.
Anton Kharitonov, expert at Traders Union, remains cautious despite the strong 12.1% surge in Morpho. He notes the absence of fundamental catalysts and finds this technically driven move vulnerable to a swift reversal. Overbought signals on the CCI and near-ceiling levels increase the risk of a correction. Unusually high intraday volatility and a lack of news support undermine long-term confidence. "Without fundamental backing or supportive news, I see limited upside beyond $2.525 and advise vigilance at current levels."
Viktoras Karapetjanc, expert at Traders Union, sees Morpho’s surge as a sign of resilient bullish structure. He views the price consolidating above all key moving averages as a foundation for further growth. While the lack of news might suggest purely technical drivers, momentum remains with buyers and volatility presents multiple trading setups. "I expect the upward momentum to continue, with a high probability of breaking past $2.525 if current conditions hold."
Jainam Mehta, market strategist, interprets Morpho’s rally as a technical breakout with mixed momentum signals. He notes the ADX neutrality and overbought CCI — factors that suggest a potential pause or tactical reversal in the coming sessions. Mehta believes traders should watch for a decisive move past $2.525 or a quick dip below $2.447 for new entries. "This setup calls for tactical positioning — I see an opportunity to fade exuberance if bearish signals strengthen intraday."
Morpho asset chart
Morpho price dynamics. Source: TradingView.

Bullish momentum confirmed as price outpaces moving averages

MORPHO/USD is trading above all closely watched moving averages, with the price at $2.502 holding above the 20-day ($2.0413), 50-day ($2.0218), and 200-day ($1.8529) levels. This alignment confirms bullish momentum on short-, medium-, and long-term timeframes, with the near-term ceiling at $2.525 and the near-term floor at $2.447. Momentum signals are firm: the MACD and RSI both indicate a buy, although the ADX signals a neutral trend. The CCI flags overbought conditions, while the Stochastic RSI sits in neutral territory. BBP is positive, showing buyers dominate intraday momentum, and the AO supports the upward move. MORPHO/USD jumped $0.27, or 12.1% today, opening with an upside gap of 3.41%. The price is trading near the session high, with intraday volatility at a notable 9.73%. Overall intraday tone is strong, leaning heavily towards buyers.

Earlier, analysts noted that Morpho maintained strong bullish momentum despite volatility, driven by expanding adoption and supportive technicals. The current move strengthens this view with a robust surge above major moving averages, and traders should closely monitor the potential for an upside extension if MORPHO/USD breaks through resistance at $2.525.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.